Cover Image

Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes

Introduction. Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers.

Saved in:

Bibliographic Details
Main Authors:	Savchenko Liudmyla G. (Author), Digtiar Nataliia I. (Author), Selikhova Liudmyla G. (Author), Kaidasheva Elvira I. (Author), Shlykova Oksana A. (Author), Vesnina Liudmyla E. (Author), Kaidashev Igor P. (Author)
Format:	Book
Published:	Sciendo, 2019-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Introduction. Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers.
Item Description:	2501-062X 10.2478/rjim-2019-0003